Navigation Links
Focused Radiation Protects Tumor Patients' Brain Function
Date:10/5/2009

Researchers recommend standard treatment with monitoring over whole-brain radiotherapy

MONDAY, Oct. 5 (HealthDay News) -- Brain tumor patients experience more learning and memory problems when whole-brain radiation therapy (WBRT) is added to standard stereotactic radiosurgery (SRS), researchers have found.

SRS delivers narrowly focused beams of radiation to the tumor site.

The study included 58 patients with one to three newly diagnosed brain metastases who were randomly selected to receive SRS alone (30 patients) or SRS plus WBRT (28 patients). However, the trial was halted early because there was a 96 percent probability that patients in the SRS/WBRT group were significantly more likely to experience declines in memory and function after four months than those receiving SRS alone.

After four months, there were four deaths (13 percent) in the patients who received SRS alone and eight deaths (29 percent) in the SRS/WBRT group, the study authors reported. After one year, 73 percent of patients in the SRS/WBRT group were recurrence-free, compared with 27 percent of patients who received SRS alone.

Despite the better outcomes among patients in the SRS/WBRT group, the researchers advised against the use of WBRT because it causes a greater decline in brain function. When brain tumors recur, they can be managed effectively with surgery if they're spotted early through regular monitoring.

"Applicability of the findings is dependent on the willingness of patients and their physicians to adhere to a schedule of close monitoring, having consistent access to high-quality MRI, having access to a neurosurgical team willing and able to perform salvage resections when indicated, and applying strict physics quality-assurance procedures for SRS," wrote Dr. Eric L. Chang, of the University of Texas M.D. Anderson Cancer Center in Houston, and colleagues.

"This study provides level 1 evidence to support the use of SRS alone in the initial management of patients newly diagnosed with one to three brain metastases. We recommend that initial SRS alone combined with close clinical monitoring should be the preferred treatment strategy for such patients," they concluded.

The study appears online and in the November print issue of The Lancet Oncology.

More information

The U.S. National Cancer Institute has more about brain tumors.



-- Robert Preidt



SOURCE: The Lancet Oncology, news release, Oct. 4, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. President Clinton Hosts Special Session on Northern Ireland; Announces New Commitments Focused on Harnessing Innovation for Development
2. Focused Learning Environment Guides Student Success
3. Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
4. Health2 Resources Announces News Portal, E-News Brief Focused on Patient Centered Medical Home
5. Kaiser Permanente Debuts New Ads Focused on Technology and Innovation
6. FertilityTies, Social Network for the Fertility-Focused Unveils New Site Design, Unique Features to Help Patients Find Fertility Doctors & More
7. Focused Health Solutions Selects Cardiocom Telehealth Technology to Support Early Intervention
8. Health Integrated Hosts Industry Collaborative Focused on the Patient-Centered Medical Home (PCMH)
9. Focused Health Solutions Partners With Emmi Solutions to Help Employers Achieve Greater Returns on Their Employee Health Care Investments
10. Expanding into New Markets with Customer-Focused Solutions, Orion Health Sees Strong Growth
11. Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: